Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
After an IRA rollover, selecting the right index fund matters for long-term growth and risk management. Compare options and choose confidently.
26,327 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Investors are weighing the fate of the retiring cruise ship dream as the cruise industry rebounds. The reality check:...
ETH struggles to reclaim the $1,900 level as the week closes, while XRP, ADA, BNB, and HYPE carve mixed paths. Trader...
The high-cost DC release posted a weak opening and was trimmed after screenings, fueling questions about DC Studios’ ...
Bitcoin trades around $63,000 as a viral altcoin skyrockets daily, up 80% in 24 hours, driving buzz across traders an...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
FTX launches a $900 million creditor payout on July 31 to eligible holders, while 45 jurisdictions remain blocked fro...
As data centers expand and AI workloads surge, a handful of tech leaders stand out as potential monster stocks hold n...
A surprising May move lit up the stock market for Super Micro Computer. This article breaks down the drivers behind t...
At age 65, the choice between Original Medicare and Medicare Advantage may determine how much retirees pay out of poc...
FCX and NEM beat quarterly estimates, but 2026 headwinds and project timing are shaping whether one stock outperforms...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...